Home › Funds › Topline Capital Management, LLC › CTKB

Topline Capital Management, LLC position in CTKB

CYTEK BIOSCIENCES INC · Industrials

Topline Capital Management, LLC reported holding 6,283,450 shares of CTKB (CYTEK BIOSCIENCES INC) in its Q2 2026 13F filing — a position valued at US$27.8M, representing 7.22% of its reported portfolio and ranking #6 among its reported holdings. Topline Capital Management, LLC has disclosed CTKB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

Latest position (Q2 2026)6.28M sh
Reported value held$27.84M
Portfolio Weight7.22%
First reportedQ4 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Topline Capital Management, LLC's CTKB position evolved

Topline Capital Management, LLC first disclosed a stake in CTKB in Q4 2024 at 236,596 shares (US$1.5M). The position peaked in Q4 2025 at 7,442,466 shares, worth US$37.6M. Across 7 filings, Topline Capital Management, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 6,283,450 shares valued at US$27.8M — a reduction of -781,031 shares quarter over quarter.. Notable position changes include a 522% increase in Q1 2025 (shares fell 15% over the following quarter), a 256% increase in Q2 2025 (shares rose 2% over the following quarter), a 33% increase in Q3 2025 (shares rose 46% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 236.60K $1.54M New
Q1 2025 1.47M $5.90M Add
Q2 2025 5.23M $17.79M Add
Q3 2025 6.94M $24.10M Add
Q4 2025 7.44M $37.58M Add
Q1 2026 7.06M $30.87M Reduce
Q2 2026 6.28M $27.84M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CTKB and 13F data

CTKB (CYTEK BIOSCIENCES INC) is a Industrials company. 35 other funds we track also report a position in CTKB — the largest reported positions include Hillhouse Capital (HHLR Advisors) (US$29.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CTKB

All CTKB fund holders →

FAQ

How long has Topline Capital Management, LLC held CTKB?

Topline Capital Management, LLC has disclosed CTKB holdings in 7 of the last 7 reported quarters, going back to Q4 2024.

What is Topline Capital Management, LLC's current position in CTKB?

As of Q2 2026, Topline Capital Management, LLC holds 6.28M shares of CTKB (CYTEK BIOSCIENCES INC), valued at $27.84M, representing 7.22% of its reported portfolio and ranking #6.

Has Topline Capital Management, LLC been buying or selling CTKB?

In the latest 13F filing (Q2 2026), Topline Capital Management, LLC reduced its position in CTKB. The position peaked in Q4 2025 at 7.44M shares.

Which other funds hold CTKB?

Other major institutional holders of CTKB include Hillhouse Capital (HHLR Advisors), among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.